Naloxegol versus Methylnaltrexone for Opioid-Induced Constipation in Critically Ill Patients

Impact of oral naloxegol vs subcutaneous methylnaltrexone in treatment of opioid-induced constipation in the hospital setting

(2022) Ricki Nero et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Constipation, diarrhea, and prophylactic laxative bowel regimens in the critically ill: A systematic review and meta-analysis

(2019) Tyler Hay et al.   JOURNAL OF CRITICAL CARE

Methylnaltrexone Versus Naloxone for Opioid-Induced Constipation in the Medical Intensive Care Unit

(2016) Cristian Merchan et al.   ANNALS OF PHARMACOTHERAPY

The role of naloxegol in the management of opioid-induced bowel dysfunction

(2016) Wojciech Leppert et al.   Therapeutic Advances in Gastroenterology

Constipation is independently associated with delirium in critically ill ventilated patients

(2015) Roland Smonig et al.   INTENSIVE CARE MEDICINE

Chronic opioid induced constipation in patients with nonmalignant pain: challenges and opportunities

(2015) Alfred D. Nelson et al.   Therapeutic Advances in Gastroenterology

Naloxegol for Opioid-Induced Constipation in Patients with Noncancer Pain

(2014) William D. Chey et al.   NEW ENGLAND JOURNAL OF MEDICINE